Combotope Therapeutics
PrivateLast Round
Accelerator
Mar 10, 2026
Total Funding Raised
$580,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Combotope Therapeutics is a Danish biotechnology company that pioneers the discovery of highly tumor-selective antibodies by targeting cancer-specific glycan-protein epitopes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Combotope Therapeutics Comparables
Compare Combotope Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GO Therapeutics | 88% | |
| TegMine Therapeutics | 85% | |
| Palleon Pharmaceuticals | 77% |
Combotope Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 10, 2026 |
Combotope Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
$580K raised from BioInnovation Institute
Recent news
Latest coverage and updates
- partners_withJun 23, 2026
Combotope Therapeutics partnered with Boehringer Ingelheim on Jun 23rd '26.
Combotope Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Combotope Therapeutics's valuation, stock price, and market status.
Is Combotope Therapeutics a public or private company?
Combotope Therapeutics is a private company.
What is the current stock price of Combotope Therapeutics?
Combotope Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Combotope Therapeutics worth (valuation)?
Valuation information for Combotope Therapeutics is not publicly available.
Can I buy Combotope Therapeutics stock?
Combotope Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Combotope Therapeutics's last funding round?
Funding round information for Combotope Therapeutics is not publicly available.
Who are the main investors in Combotope Therapeutics?
Investor information for Combotope Therapeutics is not publicly disclosed.
Will Combotope Therapeutics IPO soon?
No public IPO plans have been announced for Combotope Therapeutics.
How can I track Combotope Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Combotope Therapeutics's secondary market activity and sign up for updates.